Missing: oNK0-innate's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: oNK0-innate's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest oNK0-innate News
Apr 28, 2020
Hogan Lovells represented biopharmaceutical companies Gilead Sciences and Kite Pharma on this deal. The agreement with oNKo-innate Pty. Ltd. concerned the cancer immunotherapy research to support discovery and development of next-generation drug and engineered cell therapies focused on natural killer (NK) cells. Under the collaboration, oNKo-innate will execute screens to identify and validate targets to seed internal Gilead immuno-oncology discovery programs, and will create and evaluate NK constructs for Kite’s development of next-generation cell therapies. The Hogan Lovells team advising Gilead and Kite included Northern Virginia partner Cullen Taylor (Picture), Washington, DC partner Adam Bellack, and Northern Virginia associate Rachel Eisen.
oNK0-innate Web Traffic
oNK0-innate Frequently Asked Questions (FAQ)
When was oNK0-innate founded?
oNK0-innate was founded in 2017.
Where is oNK0-innate's headquarters?
oNK0-innate's headquarters is located at rwood Crescent , Melbourne.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.